IndustrialConnect360

Gaelic Labs: the EU Critical Medicines Act will have a positive impact on supply

Gaelic Labs is eyeing competitive benefits from its 2025 acquisition of fellow Irish beta-lactams manufacturer and further expansion.

Source: Pharmaceutical Technology, 2026-10-29. Third-party report, linked to its original publisher; IC360 has not independently verified it.

Leave a Comment

Your email address will not be published. Required fields are marked *

wpChatIcon
wpChatIcon